These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24321539)

  • 1. Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke.
    Benders MJ; van der Aa NE; Roks M; van Straaten HL; Isgum I; Viergever MA; Groenendaal F; de Vries LS; van Bel F
    J Pediatr; 2014 Mar; 164(3):481-6.e1-2. PubMed ID: 24321539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
    Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
    Thériault P; Le Béhot A; ElAli A; Rivest S
    Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.
    Li Y; Lu Z; Keogh CL; Yu SP; Wei L
    J Cereb Blood Flow Metab; 2007 May; 27(5):1043-54. PubMed ID: 17077815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin therapy for acute stroke is both safe and beneficial.
    Ehrenreich H; Hasselblatt M; Dembowski C; Cepek L; Lewczuk P; Stiefel M; Rustenbeck HH; Breiter N; Jacob S; Knerlich F; Bohn M; Poser W; Rüther E; Kochen M; Gefeller O; Gleiter C; Wessel TC; De Ryck M; Itri L; Prange H; Cerami A; Brines M; Sirén AL
    Mol Med; 2002 Aug; 8(8):495-505. PubMed ID: 12435860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants.
    Fauchère JC; Koller BM; Tschopp A; Dame C; Ruegger C; Bucher HU;
    J Pediatr; 2015 Jul; 167(1):52-7.e1-3. PubMed ID: 25863661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
    Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
    Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial).
    Cramer SC; Hill MD;
    Int J Stroke; 2014 Apr; 9(3):321-7. PubMed ID: 24588854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.
    Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI
    Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.
    Adembri C; Massagrande A; Tani A; Miranda M; Margheri M; De Gaudio R; Pellegrini-Giampietro DE
    Crit Care Med; 2008 Mar; 36(3):975-8. PubMed ID: 18176311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke?
    Bailey DM; Robach P; Thomsen JJ; Lundby C
    Stroke; 2006 Oct; 37(10):2453. PubMed ID: 16917084
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats.
    Keogh CL; Yu SP; Wei L
    J Pharmacol Exp Ther; 2007 Aug; 322(2):521-8. PubMed ID: 17494864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antierythropoietin antibodies in thalassemia patients.
    Voulgari PV; Chaidos A; Tzouvara E; Alymara V; Alamanos Y; Drosos AA; Bourantas KL
    Ann Hematol; 2004 Jan; 83(1):22-7. PubMed ID: 14530877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program.
    von Kummer R; Albers GW; Mori E;
    Int J Stroke; 2012 Oct; 7(7):589-96. PubMed ID: 22989394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients.
    Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Lombardini L; Rossi-Ferrini P
    Leukemia; 1992 Mar; 6(3):215-9. PubMed ID: 1564959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs.
    Randolph JF; Stokol T; Scarlett JM; MacLeod JN
    Am J Vet Res; 1999 May; 60(5):636-42. PubMed ID: 10328437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.